Tommy Lewander

3.2k total citations
100 papers, 2.6k citations indexed

About

Tommy Lewander is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Tommy Lewander has authored 100 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cellular and Molecular Neuroscience, 32 papers in Molecular Biology and 30 papers in Psychiatry and Mental health. Recurrent topics in Tommy Lewander's work include Neurotransmitter Receptor Influence on Behavior (32 papers), Receptor Mechanisms and Signaling (20 papers) and Schizophrenia research and treatment (19 papers). Tommy Lewander is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (32 papers), Receptor Mechanisms and Signaling (20 papers) and Schizophrenia research and treatment (19 papers). Tommy Lewander collaborates with scholars based in Sweden, United States and Norway. Tommy Lewander's co-authors include Anders Fredriksson, John Jonsson, E. Widerl�v, Bengt J. Meyerson, Trevor Archer, Uli Hacksell, Ulrik Fredrik Malt, U. G. Ahlfors, D. P. Morrison and Lars Hillered and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Tommy Lewander

97 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tommy Lewander Sweden 30 1.1k 726 638 316 287 100 2.6k
Saburo Otsuki Japan 29 1.7k 1.5× 856 1.2× 1.1k 1.7× 269 0.9× 238 0.8× 150 3.0k
Frank D. Yocca United States 26 1.2k 1.1× 699 1.0× 856 1.3× 118 0.4× 298 1.0× 51 2.3k
Frits‐Axel Wiesel Sweden 27 1.1k 1.0× 1.1k 1.6× 551 0.9× 267 0.8× 312 1.1× 65 2.5k
Alessandro Tagliamonte Italy 29 1.5k 1.3× 450 0.6× 700 1.1× 154 0.5× 279 1.0× 52 2.8k
Philip A. Berger United States 31 956 0.9× 863 1.2× 565 0.9× 225 0.7× 452 1.6× 93 3.0k
Alain Schotte Belgium 23 1.8k 1.6× 1.3k 1.7× 1.3k 2.0× 203 0.6× 308 1.1× 39 3.1k
R J Baldessarini United States 28 946 0.8× 566 0.8× 746 1.2× 195 0.6× 229 0.8× 62 2.1k
Ralph A. O’Connell United States 16 1.3k 1.2× 1.2k 1.7× 663 1.0× 190 0.6× 418 1.5× 32 3.4k
Merton Sandler United Kingdom 28 580 0.5× 419 0.6× 752 1.2× 256 0.8× 198 0.7× 57 2.4k
Richard B. Rosse United States 31 1.2k 1.0× 789 1.1× 875 1.4× 155 0.5× 251 0.9× 123 2.9k

Countries citing papers authored by Tommy Lewander

Since Specialization
Citations

This map shows the geographic impact of Tommy Lewander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tommy Lewander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tommy Lewander more than expected).

Fields of papers citing papers by Tommy Lewander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tommy Lewander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tommy Lewander. The network helps show where Tommy Lewander may publish in the future.

Co-authorship network of co-authors of Tommy Lewander

This figure shows the co-authorship network connecting the top 25 collaborators of Tommy Lewander. A scholar is included among the top collaborators of Tommy Lewander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tommy Lewander. Tommy Lewander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fredriksson, Anders, et al.. (2016). Neurocognitive functioning and outcome of the Illness Management and Recovery Program for clients with schizophrenia and schizoaffective disorder. Nordic Journal of Psychiatry. 70(6). 430–435. 5 indexed citations
2.
Lewander, Tommy, et al.. (2014). A new method for analyzing auditory brain-stem response waveforms using a moving-minimum subtraction procedure of digitized analog recordings. Neuropsychiatric Disease and Treatment. 10. 1011–1011. 8 indexed citations
3.
Landgren, Magnus, et al.. (2013). Decreased binding capacity (B max) of muscarinic acetylcholine receptors in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD). ADHD Attention Deficit and Hyperactivity Disorders. 5(3). 267–271. 8 indexed citations
4.
Lewander, Tommy, et al.. (2011). Evaluation of the Illness Management and Recovery Scale in schizophrenia and schizoaffective disorder. Schizophrenia Research. 132(2-3). 157–164. 40 indexed citations
5.
Bingefors, Kerstin, et al.. (2010). ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population. Upsala Journal of Medical Sciences. 115(1). 30–40. 27 indexed citations
6.
Malm, Ulf & Tommy Lewander. (2001). Consumer satisfaction in schizophrenia: A 2-year randomized controlled study of two community-based treatment programs. Nordic Journal of Psychiatry. 55(5). 91–96. 8 indexed citations
7.
Adam, Gail, Richard Reneland, Maria Andersson, et al.. (2000). Pharmacogenomics to predict drug response. Pharmacogenomics. 1(1). 5–14. 16 indexed citations
8.
Yan, Hongmei & Tommy Lewander. (1999). Differential tissue distribution of the enantiomers of racemic pindolol in the rat. European Neuropsychopharmacology. 10(1). 59–62. 9 indexed citations
9.
Lewander, Tommy. (1998). Efficacy and tolerability of selective serotonin reuptake inhibitors and other antidepressants acording to recent meta-analyses of randomized clinical studies. Nordic Journal of Psychiatry. 52. 98. 3 indexed citations
10.
Yu, Hong, Ye Liu, Åsa Malmberg, et al.. (1996). Differential serotoninergic and dopaminergic activities of the ( R )- and the ( S )-enantiomers of 2-(di- n -propylamino) tetralin. European Journal of Pharmacology. 303(3). 151–162. 19 indexed citations
11.
Lewander, Tommy. (1994). Neuroleptics and the neuroleptic‐induced deficit syndrome. Acta Psychiatrica Scandinavica. 89(s380). 8–13. 79 indexed citations
12.
Liu, Ye, et al.. (1993). Derivatives of 2-(dipropylamino)tetralin: effect of the C8-substituent on the interaction with 5-HT1A receptors. Journal of Medicinal Chemistry. 36(26). 4221–4229. 25 indexed citations
13.
Fredriksson, Anders, et al.. (1992). Effects of (R)-8-OH-DPAT and the enantiomers of UH-301 on motor activities in the rat: antagonism of (R)-8-OH-DPAT-induced effects. European Neuropsychopharmacology. 2(2). 141–147. 25 indexed citations
14.
Lewander, Tommy. (1992). DIFFERENTIAL DEVELOPMENT OF THERAPEUTIC DRUGS FOR PSYCHOSIS. Clinical Neuropharmacology. 15. 654A–655A. 4 indexed citations
15.
Lindgren, Silvana, et al.. (1991). (S)-UH-301 antagonizes (R)-8-OH-DPAT-indiiced cardiovascular effects in the rat. European Journal of Pharmacology. 199(3). 367–370. 17 indexed citations
16.
Köhler, C., et al.. (1990). Biochemical pharmacology of the atypical neuroleptic remoxipride. Acta Psychiatrica Scandinavica. 82(S358). 27–36. 70 indexed citations
17.
Morrison, D. P., et al.. (1990). Safety evaluation in both short‐ and long‐term treatment of schizophrenia with remoxipride. Acta Psychiatrica Scandinavica. 82(S358). 164–169. 16 indexed citations
18.
Lewander, Tommy, et al.. (1990). Clinical profile of remoxipride ‐ a combined analysis of a comparative double‐blind multicentre trial programme. Acta Psychiatrica Scandinavica. 82(S358). 92–98. 106 indexed citations
19.
Luthman, J., et al.. (1989). Effects ofd-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Psychopharmacology. 99(4). 550–557. 79 indexed citations
20.
Lewander, Tommy, T H Joh, & D J Reis. (1977). Tyrosine hydroxylase: delayed activation in central noradrenergic neurons and induction in adrenal medulla elicited by stimulation of central cholinergic receptors.. Journal of Pharmacology and Experimental Therapeutics. 200(3). 523–534. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saburo Otsuki Breakdown of academic impact, for papers by Frank D. Yocca Breakdown of academic impact, for papers by Frits‐Axel Wiesel Breakdown of academic impact, for papers by Alessandro Tagliamonte Breakdown of academic impact, for papers by Philip A. Berger Breakdown of academic impact, for papers by Alain Schotte Breakdown of academic impact, for papers by R J Baldessarini Breakdown of academic impact, for papers by Ralph A. O’Connell Breakdown of academic impact, for papers by Merton Sandler Breakdown of academic impact, for papers by Richard B. Rosse
Rankless by CCL
2026